FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083117013> ?p ?o ?g. }

• W2083117013 endingPage "493" @default.
• W2083117013 startingPage "487" @default.
• W2083117013 abstract "Plasma free T4 (FT4) concentrations could be increased during hemodialysis in patients with chronic renal failure (CRF) because an increase in non-esterified fatty acids (NEFA) could interfere with the binding of T4 to thyroxine-binding globulin. To evaluate the effect of hemodialysis on the FT4 concentration in patients with CRF, we measured the FT4 in 39 patients with CRF by four assay methods including equilibrium dialysis, the 125I-T4 analog method and enzyme immunoassay. The addition of the fatty acid sodium oleate to normal pooled sera led to a marked increase in FT4 as measured by equilibrium dialysis (Model FT4). A moderate increase in the serum FT4 concentration also was observed with an IMX enzyme immunoassay kit, whereas the Coat-A-Count analog method demonstrated no interference by sodium oleate. The mean serum FT4 prior to hemodialysis measured by equilibrium dialysis did not differ significantly from that in the normal control, although those measured by analog methods (Coat-A-Count and Amerlex) and IMX were subnormal. The FT4 by IMX were albumin-dependent, and the values decreased as the samples were serially diluted, but Model FT4 was not affected by the albumin level or the serial dilution. FT4 by Model FT4 showed a marked increase beginning 10min after the start of dialysis, and it correlated well with the plasma concentration of NEFA and the NEFA/albumin molar ratio. The other three assay methods, including one which is not affected by NEFA, did not show a change in FT4 at 10min, but a significant increase of 11 to 17% was observed by the end of dialysis. The TSH concentration decreased significantly during hemodialysis. These data suggest that (1) the low serum FT4 in hemodialysis patients measured by some immunoassay methods may be an underestimation due to the low albumin level; (2) FT4 actually increases during hemodialysis due to the actual increase in NEFA, although the marked increase in FT4 during hemodialysis as measured by equilibrium dialysis is an overestimation due to the in vitro generation of NEFA; and (3) one should beware of abberations in thyroid hormone parameters during hemodialysis and potential complications." @default.
• W2083117013 created "2016-06-24" @default.
• W2083117013 creator A5007148412 @default.
• W2083117013 creator A5010496747 @default.
• W2083117013 creator A5051488243 @default.
• W2083117013 creator A5052408363 @default.
• W2083117013 creator A5058898445 @default.
• W2083117013 creator A5064080554 @default.
• W2083117013 creator A5077581552 @default.
• W2083117013 date "1996-01-01" @default.
• W2083117013 modified "2023-10-14" @default.
• W2083117013 title "Plasma Free Thyroxine (FT4) Concentrations during Hemodialysis in Patients with Chronic Renal Failure: Effects of Plasma Non-Esterified Fatty Acids on FT4 Measurement." @default.
• W2083117013 cites W1523651302 @default.
• W2083117013 cites W1905032654 @default.
• W2083117013 cites W1949481233 @default.
• W2083117013 cites W1952077050 @default.
• W2083117013 cites W1952806310 @default.
• W2083117013 cites W1967981321 @default.
• W2083117013 cites W1979818727 @default.
• W2083117013 cites W2017768507 @default.
• W2083117013 cites W2023583183 @default.
• W2083117013 cites W2044555720 @default.
• W2083117013 cites W2045578041 @default.
• W2083117013 cites W2088379662 @default.
• W2083117013 cites W2105432376 @default.
• W2083117013 cites W2113534883 @default.
• W2083117013 cites W2152167879 @default.
• W2083117013 cites W2166992073 @default.
• W2083117013 cites W2258215810 @default.
• W2083117013 cites W2440781970 @default.
• W2083117013 cites W2524493343 @default.
• W2083117013 doi "https://doi.org/10.1507/endocrj.43.487" @default.
• W2083117013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8980887" @default.
• W2083117013 hasPublicationYear "1996" @default.
• W2083117013 type Work @default.
• W2083117013 sameAs 2083117013 @default.
• W2083117013 citedByCount "11" @default.
• W2083117013 countsByYear W20831170132013 @default.
• W2083117013 countsByYear W20831170132014 @default.
• W2083117013 countsByYear W20831170132019 @default.
• W2083117013 countsByYear W20831170132021 @default.
• W2083117013 crossrefType "journal-article" @default.
• W2083117013 hasAuthorship W2083117013A5007148412 @default.
• W2083117013 hasAuthorship W2083117013A5010496747 @default.
• W2083117013 hasAuthorship W2083117013A5051488243 @default.
• W2083117013 hasAuthorship W2083117013A5052408363 @default.
• W2083117013 hasAuthorship W2083117013A5058898445 @default.
• W2083117013 hasAuthorship W2083117013A5064080554 @default.
• W2083117013 hasAuthorship W2083117013A5077581552 @default.
• W2083117013 hasBestOaLocation W20831170131 @default.
• W2083117013 hasConcept C126322002 @default.
• W2083117013 hasConcept C134018914 @default.
• W2083117013 hasConcept C159654299 @default.
• W2083117013 hasConcept C165616093 @default.
• W2083117013 hasConcept C178790620 @default.
• W2083117013 hasConcept C185592680 @default.
• W2083117013 hasConcept C203014093 @default.
• W2083117013 hasConcept C2776125364 @default.
• W2083117013 hasConcept C2778063415 @default.
• W2083117013 hasConcept C2779772378 @default.
• W2083117013 hasConcept C2779978075 @default.
• W2083117013 hasConcept C2780420688 @default.
• W2083117013 hasConcept C537181965 @default.
• W2083117013 hasConcept C543025807 @default.
• W2083117013 hasConcept C55493867 @default.
• W2083117013 hasConcept C71924100 @default.
• W2083117013 hasConcept C81358767 @default.
• W2083117013 hasConceptScore W2083117013C126322002 @default.
• W2083117013 hasConceptScore W2083117013C134018914 @default.
• W2083117013 hasConceptScore W2083117013C159654299 @default.
• W2083117013 hasConceptScore W2083117013C165616093 @default.
• W2083117013 hasConceptScore W2083117013C178790620 @default.
• W2083117013 hasConceptScore W2083117013C185592680 @default.
• W2083117013 hasConceptScore W2083117013C203014093 @default.
• W2083117013 hasConceptScore W2083117013C2776125364 @default.
• W2083117013 hasConceptScore W2083117013C2778063415 @default.
• W2083117013 hasConceptScore W2083117013C2779772378 @default.
• W2083117013 hasConceptScore W2083117013C2779978075 @default.
• W2083117013 hasConceptScore W2083117013C2780420688 @default.
• W2083117013 hasConceptScore W2083117013C537181965 @default.
• W2083117013 hasConceptScore W2083117013C543025807 @default.
• W2083117013 hasConceptScore W2083117013C55493867 @default.
• W2083117013 hasConceptScore W2083117013C71924100 @default.
• W2083117013 hasConceptScore W2083117013C81358767 @default.
• W2083117013 hasIssue "5" @default.
• W2083117013 hasLocation W20831170131 @default.
• W2083117013 hasLocation W20831170132 @default.
• W2083117013 hasOpenAccess W2083117013 @default.
• W2083117013 hasPrimaryLocation W20831170131 @default.
• W2083117013 hasRelatedWork W1571926541 @default.
• W2083117013 hasRelatedWork W1981985450 @default.
• W2083117013 hasRelatedWork W2036285678 @default.
• W2083117013 hasRelatedWork W2076113938 @default.
• W2083117013 hasRelatedWork W2301247038 @default.
• W2083117013 hasRelatedWork W2377109797 @default.
• W2083117013 hasRelatedWork W2441273631 @default.
• W2083117013 hasRelatedWork W2590273458 @default.
• W2083117013 hasRelatedWork W2735746566 @default.

• next